Q: What is Adaptive Biotechnologies Corporation Common Stock's WACC?

Adaptive Biotechnologies Corporation Common Stock (ADPT) has a Weighted Average Cost of Capital (WACC) of 8.72%. This is calculated using a Cost of Equity of 8.71% (via CAPM with a beta of 1.00) and a pre-tax Cost of Debt of 9.01%, with an equity weight of 95.54% in the capital structure.

Q: Is Adaptive Biotechnologies Corporation Common Stock's WACC high or low?

Adaptive Biotechnologies Corporation Common Stock's WACC of 8.72% falls within the typical 8-12% range for mid-cap growth companies. WACC is used as the discount rate in DCF valuations — a lower WACC results in higher present values of future cash flows.

Q: How is Adaptive Biotechnologies Corporation Common Stock's WACC calculated?

Adaptive Biotechnologies Corporation Common Stock's WACC is calculated using the formula: WACC = (E/V × Re) + (D/V × Rd × (1-T)). The Cost of Equity (Re) of 8.71% is derived from the CAPM model using a beta of 1.00. The pre-tax Cost of Debt (Rd) is 9.01%. The capital structure is 95.54% equity and 4.46% debt.

Question 1

What is Adaptive Biotechnologies Corporation Common Stock's WACC?

Accepted Answer

Adaptive Biotechnologies Corporation Common Stock（ADPT） WACC 解读

Adaptive Biotechnologies Corporation Common Stock（ADPT）当前估算的 WACC 为 8.72%。其中股权成本为 8.71%，税前债务成本为 9.01%，股权权重为 95.54%。这个折现率可以直接作为 DCF 估值和资本结构判断的起点。

处于常见区间，适合作为成熟公司 DCF 假设的基准参考。

Question 2

Is Adaptive Biotechnologies Corporation Common Stock's WACC high or low?

Accepted Answer

Adaptive Biotechnologies Corporation Common Stock（ADPT） WACC 解读

Adaptive Biotechnologies Corporation Common Stock（ADPT）当前估算的 WACC 为 8.72%。其中股权成本为 8.71%，税前债务成本为 9.01%，股权权重为 95.54%。这个折现率可以直接作为 DCF 估值和资本结构判断的起点。

处于常见区间，适合作为成熟公司 DCF 假设的基准参考。

Question 3

How is Adaptive Biotechnologies Corporation Common Stock's WACC calculated?

Accepted Answer

Adaptive Biotechnologies Corporation Common Stock（ADPT） WACC 解读

Adaptive Biotechnologies Corporation Common Stock（ADPT）当前估算的 WACC 为 8.72%。其中股权成本为 8.71%，税前债务成本为 9.01%，股权权重为 95.54%。这个折现率可以直接作为 DCF 估值和资本结构判断的起点。

处于常见区间，适合作为成熟公司 DCF 假设的基准参考。

Adaptive Biotechnologies Corporation Common Stock (ADPT) — WACC 分析

WACC 构成

解读

Adaptive Biotechnologies Corporation Common Stock（ADPT）WACC：8.72%

WACC计算器

Adaptive Biotechnologies Corporation Common Stock（ADPT） WACC 解读

ADPT 公司分析

ADPT DCF 估值

继续做同行对比